Ford Grew Profits While Selling Fewer Cars. Here Is Why That Matters.
A 13.3% return on invested capital and $4.7 billion in free cash flow reframe what looked like a volume problem.
A 13.3% return on invested capital and $4.7 billion in free cash flow reframe what looked like a volume problem.
With shares down about 41% in a month and Phase 3 oral trials just launched, Viking Therapeutics is cheaper now than it has been in years, and Lilly’s antitrust overhang may matter most in any buyout talk.
Welltower, Prologis, and VICI are not just surviving higher rates. They are growing through them.
Anthropic’s November debut follows a spike in CoreWeave’s credit stress
When every hyperscaler sells every frontier model, the fight shifts to power, price, and data ownership.
SAP reports Q3 results on October 21. Watch cloud backlog.
Adjusted EPS of $15.93, $7.75B in revenue, and $15.5T in AUM
September inflation lands today, and the core reading tests the Fed’s split on 2027.
Microfluidics is turning lab screens into desktop products
Autonomous and KBW see 10% to 15% property-cat rate cuts at Jan. 1 renewals, boosting primary insurers’ margins.